Bookedited by Robert B. Raffa, Ronald J. Tallarida.
Contents:
Short introduction and history / Robert B. Raffa
Patient's perspective / Robert B. Raffa and Kathy Martin
Oncology nurse's perspective / Jamie S. Myers
Oncology pharmacist's perspective / Rachel Clark-Vetri
The impact of chemo brain on the patient with a high grade glioma / Michele R. Lucas
Oncology pharmacist's perspective / Rachel Clark-Vetri
The impact of chemo brain on the patient with a high grade glioma / Michele R. Lucas
Neurocognitive effects of childhood cancer treatment / Jennifer Costa
The economic burden / Albert I. Wertheimer
Designing conceptual model-based research in chemotherapy-related changes in cognitive function / Lisa M. Hess
Neuropsychologic testing for chemotherapy-related cognitive impairment / Jamie S. Myers
Imaging as a means of studying chemotherapy-related cognitive impairment / Robert B. Raffa
Chemotherapy associated central nervous system damage / Jørg Dietrich
Is systemic anti-cancer therapy neurotoxic? Does chemo brain exist? And should we rename it? / Sophie Taillibert
Evaluation of multiple neurotoxic outcomes in cancer chemotherapy / Bernard Weiss
Chemotherapy-related visual system toxicity / Robert B. Raffa
The possible role of cytokines in chemotherapy-induced cognitive deficits / Jamie S. Myers
Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy / Swati Nagar
Combination analysis / Ronald J. Tallarida
Animal models / Ellen A. Walker
Chemo brain (chemo fog) as a potential side effect of doxorubicin administration : role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction / Christopher D. Aluise ... [et al.]
Effects of 5-FU / Peter M. Wigmore ... [et al.]
Future directions / Robert B. Raffa and Ronald J. Tallarida.
Location
Version
Call Number
Items